<DOC>
	<DOCNO>NCT02383797</DOCNO>
	<brief_summary>The investigatoris carefully select cartilage-hair hypoplasia patient unexposed varicella ( VZV ) immunize patient control manner VZV vaccine . Patients select basis disease severity degree immunodeficiency ( include CD4+ T-cell count ) . Any potential complication VZV immunization , rash , discuss patients/caregivers beforehand acyclovir use treat VZV relate symptom , consistent current practice . The investigator verify development immune response vaccination test VZV antibody cell-mediated immunity .</brief_summary>
	<brief_title>Immunodeficiency Cartilage-hair Hypoplasia : Sub-project Safety Vaccination Against Chickenpox</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Hirschsprung Disease</mesh_term>
	<mesh_term>Osteochondrodysplasias</mesh_term>
	<criteria>genetically confirm cartilagehair hypoplasia diagnosis age &gt; 12 month history chickenpox inform concent patient/caregiver . positive serum IgG varicella zoster virus low CD4+ cell count ( &lt; 15 % &lt; 200 cells/mm3 ) clinical laboratory sign severe immunodeficiency ongoing intravenous subcutaneous immunoglobulin treatment</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>